The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIOMED INC | COM | 003654100 | 141,319 | 2,150,000 | SH | SOLE | 2,150,000 | 0 | 0 | ||
| ACURA PHARMACEUTICALS INC | COM NEW | 00509L703 | 9,684 | 9,871,985 | SH | SOLE | 9,871,985 | 0 | 0 | ||
| CORIUM INTL INC | COM | 21887L107 | 128,047 | 9,353,304 | SH | SOLE | 9,353,304 | 0 | 0 | ||
| ENDOLOGIX INC | COM | 29266S106 | 24,875 | 1,257,468 | SH | SOLE | 1,257,468 | 0 | 0 | ||
| ENTELLUS MED INC | COM | 29363K105 | 98,647 | 3,813,197 | SH | SOLE | 3,813,197 | 0 | 0 | ||
| MEDICINOVA INC | COM NEW | 58468P206 | 4,623 | 1,170,370 | SH | SOLE | 1,170,370 | 0 | 0 | ||
| REVANCE THERAPEUTICS INC | COM | 761330109 | 146,854 | 4,592,047 | SH | SOLE | 4,592,047 | 0 | 0 | ||